Clinical Trials Arena October 31, 2025
GlobalData projects roughly 13% of trials remain undisclosed in early stages, meaning the overall volume is still underreported at the time of initiation.
According to GlobalData’s Clinical Trials Database, the first half of 2025 has shown a clear increase in global clinical trial initiations, marking a shift from the slowdown of recent years. A combination of stronger biotech funding, fewer trial cancellations, and faster movement from planning to study start has supported this rise. One example is Medpace’s Q2 performance, where revenue grew by double digits and guidance for FY2025 was raised by 11%. The company highlighted lower cancellations, faster backlog conversion, and more efficient start-up processes as drivers. Its results not only lifted its own share price but also...
Today's Sponsors
Today's Sponsor